These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26769658)

  • 21. Therapeutic approach for neuronal disease by regulating renin-angiotensin system.
    Ohshima K; Mogi M; Horiuchi M
    Curr Hypertens Rev; 2013 May; 9(2):99-107. PubMed ID: 23971691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale for combining blockers of the renin-angiotensin system.
    Azizi M; Wuerzner G
    Semin Nephrol; 2007 Sep; 27(5):544-54. PubMed ID: 17868792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renin inhibition--benefit beyond hypertension control.
    Kher V
    J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
    Gerc V; Buksa M; Loza V; Kulic M
    Med Arh; 2009; 63(6):343-9. PubMed ID: 20380117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ; Smith SM; Choksi R
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensins in Alzheimer's disease - friend or foe?
    Kehoe PG; Miners S; Love S
    Trends Neurosci; 2009 Dec; 32(12):619-28. PubMed ID: 19796831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the renin-angiotensin system on abdominal aortic aneurysms.
    Malekzadeh S; Fraga-Silva RA; Trachet B; Montecucco F; Mach F; Stergiopulos N
    Eur J Clin Invest; 2013 Dec; 43(12):1328-38. PubMed ID: 24138426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Alzheimer disease--contribution of renin-angiotensin system to Alzheimer disease progression].
    Ohrui T
    Nihon Rinsho; 2012 Sep; 70(9):1599-603. PubMed ID: 23012810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options.
    Grace JA; Herath CB; Mak KY; Burrell LM; Angus PW
    Clin Sci (Lond); 2012 Aug; 123(4):225-39. PubMed ID: 22548407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotection with angiotensin receptor antagonists: a review of the evidence and potential mechanisms.
    Wilms H; Rosenstiel P; Unger T; Deuschl G; Lucius R
    Am J Cardiovasc Drugs; 2005; 5(4):245-53. PubMed ID: 15984907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a review of the current evidence.
    Tsouli SG; Liberopoulos EN; Kiortsis DN; Mikhailidis DP; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):1-15. PubMed ID: 16703216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renin angiotensin system (RAS) blockade and diabetic microvascular complications in the eye and kidney.
    Bilous R
    Prim Care Diabetes; 2008 Dec; 2(4):201-2. PubMed ID: 18760685
    [No Abstract]   [Full Text] [Related]  

  • 34. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB; Coffman TM
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin receptor blockers: Focus on cardiac and renal injury.
    Arumugam S; Sreedhar R; Thandavarayan RA; Karuppagounder V; Krishnamurthy P; Suzuki K; Nakamura M; Watanabe K
    Trends Cardiovasc Med; 2016 Apr; 26(3):221-8. PubMed ID: 26169314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On target to dual block RAS?
    Papadopoulos DP; Papademetriou V; Makris TK
    Angiology; 2009 Dec-2010 Jan; 60(6):739-49. PubMed ID: 19144653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-diabetic effect of blockade of the renin-angiotensin system.
    Ando K; Fujita T
    Diabetes Obes Metab; 2006 Jul; 8(4):396-403. PubMed ID: 16776746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progression of cardiovascular damage: the role of renin-angiotensin system blockade.
    Probstfield JL; O'Brien KD
    Am J Cardiol; 2010 Jan; 105(1 Suppl):10A-20A. PubMed ID: 20102969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of RAAS inhibition on stroke prevention].
    Tanahashi N
    Nihon Rinsho; 2012 Sep; 70(9):1582-7. PubMed ID: 23012807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry.
    Bramlage P; Schmieder RE; Gitt AK; Baumgart P; Mahfoud F; Buhck H; Ouarrak T; Ehmen M; Potthoff SA;
    Trials; 2015 Dec; 16():581. PubMed ID: 26686682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.